The Horse:Your Guide To Equine Health Care provides monthly equine health care information to horse owners, breeders, veterinarians, barn/farm managers, trainer/riding instructors, and others involved in the hands-on care of the horse.
Issue link: https://thehorse.epubxp.com/i/475867
7 April 2015 The horse TheHorse.com Fact sheets Equine Navicular Syndrome learn about the most frequent cause of equine forelimb lameness and management options. Sponsored by Dechra. TheHorse.com/29981 ➧ FIND tHIs VIDEO AND OtHErs At Thehorse.CoM/ free-rePorTs B luegrass Equine DIGEST ca.uky.edu/equine ❙ The horse.com ❙ m ay 2014 A s many of us know, horse owner- ship is like eating potato chips; you can't have just one! The def - nition of too many horses depends on who you are asking and what param- eters you are considering. Before trying to decide if your checkbook can stand to take on one more horse, ask yourself, "Is my land capable?" More specifcally, can the land you have support the horses you own in an economical and environ - mentally friendly way? There are tools to answer this question, one of which is the National Cooperative Soil Survey (NCSS) program. National Cooperative Soil Survey The NCSS program began in 1896 as an attempt to survey and map soils in the United States. The program started small, surveying only 2.8 million acres in Maryland, Connecticut, Utah, and New Mexico. Today, soil survey data is available online for the entire country as the Web Soil Survey (WSS) and is maintained by the USDA-NRCS (United States Department of Agriculture, Natu- ral Resources Conservation Service). The NCSS has a wealth of information and uses, both in and out of agriculture. Using the Web Soil Survey One of the many features of the WSS is the ability to calculate a farm's car- rying capacity, answering the question, "How many horses can my farm hold?" Below is a step-by-step guide to view- ing soil characteristics for any piece of land in the United States. A PowerPoint presentation has also been created to graphically walk you through each step and can be found on the UK Horse Pasture Evaluation Facebook page . For this example, we will select roughly 80 acres of prime horse pasture located on the University of Kentucky Research Farm near Lexington. 1. Navigate to the Web Soil Survey or search for "web soil survey." Click the green "START WSS" button. 2. Enter Address Click the dropdown arrows, enter the address, and click view. 3. Find Your Area Entering an address in WSS is like using a GPS—it isn't always completely accurate. Use the "+" magnifying glass to zoom in, the "-" magnifying glass to zoom out, and the "hand tool" to move the map A soil survey can help you calculate your farm's carrying capacity. thinkstock.com Articles of Interest It's Haymaking Season UK Equine Influenza Study Receives Funding from Zoetis UKVDL Bulletin Alert: Unapproved Compounded Drugs Is My Horse a Tick Magnet? Weed of the Month: Buttercups Chart: Pasture Weeds ' Response to Herbicides Eastern Tent Caterpillars on the Move in Central Kentucky UK Cooperative Extension Celebrates 100 Years Follow us on Twitter UKVDL Reminder of CEM Collection Guidelines Crowdfunding Project Receives Recognition Equine Farm and Facilities Expo Gluck Center to Host Annual Midwestern Conference of Parasitologists Upcoming Events 1 How Many Horses Can Your Farm Hold? stay on top of equine health, care, management, welfare, and industry news. sign up for weekly and monthly e-newsletters brought to you by Thehorse.com. sPeCIalTy E-NEwslEttErs TheHorse.com offers the following special interest weekly e-newsletters: nutrition, lameness, and reader favorites TheHorse.com offers the following special interest monthly e-newsletters: Behavior, Breeding, equinomics, older horse Care, and sports Medicine Bluegrass equine digest is published monthly in partnership with UK Ag Equine and the Gluck Equine research Center and is supported by Zoetis. Bisphosphonate For use in horses only. Brief Summary (For Full Prescribing Information, see package insert) Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. DesCription: Clodronate disodium is a non-amino, chloro-containing bisphosphonate. Chemically, clodronate disodium is (dichloromethylene) diphosphonic acid disodium salt and is manufactured from the tetrahydrate form. inDiCation: For the control of clinical signs associated with navicular syndrome in horses. ContrainDiCations: Horses with hypersensitivity to clodronate disodium should not receive OSPHOS. Warnings: Do not use in horses intended for human consumption. Human Warnings: Not for human use. Keep this and all drugs out of the reach of children. Consult a physician in case of accidental human exposure. preCautions: As a class, bisphosphonates may be associated with gastrointestinal and renal toxicity. Sensitivity to drug associated adverse reactions varies with the individual patient. Renal and gastrointestinal adverse reactions may be associated with plasma concentrations of the drug. Bisphosphonates are excreted by the kidney; therefore, conditions causing renal impairment may increase plasma bisphosphonate concentrations resulting in an increased risk for adverse reactions. Concurrent administration of other potentially nephrotoxic drugs should be approached with caution and renal function should be monitored. Use of bisphosphonates in patients with conditions or diseases affecting renal function is not recommended. Administration of bisphosphonates has been associated with abdominal pain (colic), discomfort, and agitation in horses. Clinical signs usually occur shortly after drug administration and may be associated with alterations in intestinal motility. In horses treated with OSPHOS these clinical signs usually began within 2 hours of treatment. Horses should be monitored for at least 2 hours following administration of OSPHOS. Bisphosphonates affect plasma concentrations of some minerals and electrolytes such as calcium, magnesium and potassium, immediately post-treatment, with effects lasting up to several hours. Caution should be used when administering bisphosphonates to horses with conditions affecting mineral or electrolyte homeostasis (e.g. hyperkalemic periodic paralysis, hypocalcemia, etc.). The safe use of OSPHOS has not been evaluated in horses less than 4 years of age. The effect of bisphosphonates on the skeleton of growing horses has not been studied; however, bisphosphonates inhibit osteoclast activity which impacts bone turnover and may affect bone growth. Bisphosphonates should not be used in pregnant or lactating mares, or mares intended for breeding. The safe use of OSPHOS has not been evaluated in breeding horses or pregnant or lactating mares. Bisphosphonates are incorporated into the bone matrix, from where they are gradually released over periods of months to years. The extent of bisphosphonate incorporation into adult bone, and hence, the amount available for release back into the systemic circulation, is directly related to the total dose and duration of bisphosphonate use. Bisphosphonates have been shown to cause fetal developmental abnormalities in laboratory animals. The uptake of bisphosphonates into fetal bone may be greater than into maternal bone creating a possible risk for skeletal or other abnormalities in the fetus. Many drugs, including bisphosphonates, may be excreted in milk and may be absorbed by nursing animals. Increased bone fragility has been observed in animals treated with bisphosphonates at high doses or for long periods of time. Bisphosphonates inhibit bone resorption and decrease bone turnover which may lead to an inability to repair micro damage within the bone. In humans, atypical femur fractures have been reported in patients on long term bisphosphonate therapy; however, a causal relationship has not been established. aDverse reaCtions: The most common adverse reactions reported in the eld study were clinical signs of discomfort or nervousness, colic and/or pawing. Other signs reported were lip licking, yawning, head shaking, injection site swelling, and hives/pruritus. Distributed by: Dechra Veterinary Products 7015 College Boulevard, Suite 525 Overland Park, KS 66211, 866-933-2472 © 2013 Dechra Ltd. OSPHOS is a registered trademark of Dechra Ltd. All rights reserved. NADA 141-427, Approved by FDA OSPHOS ® (clodronate injection) ask the horse live Navicular Syndrome: Your Questions Answered Diagnosing, treating, and managing horses with navicular syndrome is challenging. But, with care and a balance of farrier work, drug treatment, and controlled exercise, many "navicular" horses can go on to lead productive and comfortable lives. learn how to help your horse during our hourlong live event on March 26, 2015, at 8 p.m. EDt. Sponsored by Ceva. ➧ sIGN UP Or lIstEN tO ArCHIVED EVENts At Thehorse.CoM/asKThehorselIVe University oF kentUcky seminars scott McClure, DVM, PhD, Dipl. ACVs, associate professor of equine surgery at Iowa state University, explains what a shock wave is, how it works, and how this therapy might help horses with a variety of conditions, from leg lameness to back and neck pain. ➧ FIND tHIs sEMINAr AND OtHErs At Thehorse.CoM/uKleCTures videos How Your Horse Sees theHorse.com/30552 Trailer Safety Check theHorse.com/30560 ➧ FIND tHEsE AND OtHErs At Thehorse.CoM/ VIdeos TheHorse.com/Across-The-Fence istock.com